| Year |
Citation |
Score |
| 2012 |
Amatangelo MD, Goodyear S, Varma D, Stearns ME. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer. Carcinogenesis. 33: 1965-75. PMID 22791812 DOI: 10.1093/Carcin/Bgs227 |
0.661 |
|
| 2012 |
Wang M, Hu Y, Amantagelo MD, Stearns ME. Retraction: Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Molecular Cancer Research : McR. 10: 570. PMID 22434856 DOI: 10.1158/1541-7786.Mcr-12-0085 |
0.436 |
|
| 2012 |
Jun S, Abedin M, Will S, Mohammadi SE, Rahman M, Garcia F, Stearns M. BSR-8 Establishment and Characterization of a Novel Gallbladder Cell Line to Study the Gender Differences in the Development of Gallbladder Cancer Associated with Gallstones Gender Medicine. 9: S96. DOI: 10.1016/J.Genm.2011.09.010 |
0.342 |
|
| 2012 |
Amatangelo MD, Stearns ME. Reactivation of epithelial-mesenchymal transition in invasive and metastatic cancer Signaling Pathways and Molecular Mediators in Metastasis. 2147483647: 13-69. DOI: 10.1007/978-94-007-2558-4_2 |
0.321 |
|
| 2011 |
Stearns ME, Wang M. Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors. Translational Oncology. 4: 147-56. PMID 21633670 DOI: 10.1593/Tlo.10286 |
0.469 |
|
| 2011 |
Wang M, Hu Y, Amatangelo MD, Stearns ME. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Molecular Cancer Research : McR. 9: 36-50. PMID 21148031 DOI: 10.1158/1541-7786.Mcr-10-0158 |
0.311 |
|
| 2011 |
Stearns ME, Wang M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors1 Translational Oncology. 4: 147-156. DOI: 10.1593/tlo.10286 |
0.378 |
|
| 2010 |
Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. The American Journal of Pathology. 177: 3169-79. PMID 20971741 DOI: 10.2353/Ajpath.2010.100330 |
0.649 |
|
| 2010 |
Abedin MZ, Suresh N, Jun S, Sun W, Rahman MT, Garcia FU, Stearns ME. 847 Establishment and Characterization of a Novel Gallbladder Cell Line to Study Gallbladder Cancer and Gallstones Gastroenterology. 138: S-798. DOI: 10.1016/S0016-5085(10)63675-X |
0.359 |
|
| 2009 |
Goodyear SM, Kheyfets SB, Garcia FU, Stearns ME. Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. The Prostate. 69: 982-90. PMID 19301310 DOI: 10.1002/Pros.20945 |
0.663 |
|
| 2009 |
Goodyear SM, Amatangelo MD, Stearns ME. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense. The Prostate. 69: 689-98. PMID 19143028 DOI: 10.1002/Pros.20918 |
0.645 |
|
| 2009 |
Wang M, Hu Y, Stearns ME. RPS2: a novel therapeutic target in prostate cancer. Journal of Experimental & Clinical Cancer Research : Cr. 28: 6. PMID 19138403 DOI: 10.1186/1756-9966-28-6 |
0.472 |
|
| 2007 |
Hu Y, Wang M, Veverka K, Garcia FU, Stearns ME. The ABCA5 protein: a urine diagnostic marker for prostatic intraepithelial neoplasia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 929-38. PMID 17289887 DOI: 10.1158/1078-0432.Ccr-06-1718 |
0.444 |
|
| 2007 |
Stearns ME, Hu Y, Wang M, Veverka KA. Identification of ABCA5 as a tissue and urine diagnostic marker for PIN Journal of Clinical Oncology. 25: 15508-15508. DOI: 10.1200/jco.2007.25.18_suppl.15508 |
0.339 |
|
| 2006 |
Stearns ME, Hu Y, Wang M, Veverka K. Identification of ABCA5 as a tissue and urine diagnostic marker for prostatic intraepithelial epithelial or PIN Journal of Clinical Oncology. 24: 10089-10089. DOI: 10.1200/jco.2006.24.18_suppl.10089 |
0.311 |
|
| 2005 |
Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A. Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor. Oncogene. 24: 6848-54. PMID 16007172 DOI: 10.1038/Sj.Onc.1208815 |
0.529 |
|
| 2005 |
Stearns M, Tran J, Francis MK, Zhang H, Sell C. Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells. Cancer Research. 65: 2085-8. PMID 15781617 DOI: 10.1158/0008-5472.Can-04-4100 |
0.424 |
|
| 2004 |
Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Research. 64: 4693-8. PMID 15256432 DOI: 10.1158/0008-5472.Can-03-3437 |
0.441 |
|
| 2004 |
Stearns ME, Wang M, Hu Y, Kim G, Garcia FU. Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 84: 785-95. PMID 15107801 DOI: 10.1038/Labinvest.3700075 |
0.378 |
|
| 2004 |
Ohkia A, Hu Y, Wang M, Garcia FU, Stearns ME. Evidence for prostate cancer-associated diagnostic marker-1: immunohistochemistry and in situ hybridization studies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2452-8. PMID 15073124 DOI: 10.1158/1078-0432.Ccr-03-0170 |
0.464 |
|
| 2003 |
Wang M, Hu Y, Stearns ME. A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells. British Journal of Cancer. 88: 1605-14. PMID 12771930 DOI: 10.1038/Sj.Bjc.6600855 |
0.362 |
|
| 2002 |
Wang M, Hu Y, Shima I, Stearns ME. IL-10/IL-10 receptor signaling regulates TIMP-1 expression in primary human prostate tumor lines. Cancer Biology & Therapy. 1: 556-63. PMID 12496489 DOI: 10.4161/Cbt.1.5.222 |
0.395 |
|
| 2000 |
Garcia FU, Taylor CA, Hou JS, Rukstalis DB, Stearns ME. Increased cellularity of tumor-encased native vessels in prostate carcinoma is a marker for tumor progression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 13: 717-22. PMID 10912929 DOI: 10.1038/Modpathol.3880124 |
0.46 |
|
| 1999 |
Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride- simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line Clinical and Experimental Metastasis. 17: 687-694. PMID 10919714 DOI: 10.1023/A:1006728119549 |
0.474 |
|
| 1999 |
Wang M, Liu A, Garcia FU, Rhim JS, Stearns ME. Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT. International Journal of Oncology. 14: 1185-95. PMID 10339677 DOI: 10.3892/Ijo.14.6.1185 |
0.372 |
|
| 1998 |
Stearns ME, Ware JL, Agus DB, Chang CJ, Fidler IJ, Fife RS, Goode R, Holmes E, Kinch MS, Peehl DM, Pretlow TG, Thalmann GN. Workgroup 2: human xenograft models of prostate cancer. The Prostate. 36: 56-8. PMID 9650917 DOI: 10.1002/(Sici)1097-0045(19980615)36:1<56::Aid-Pros10>3.0.Co;2-H |
0.32 |
|
| 1996 |
Fudge K, Bostwick DG, Stearns ME. Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia. The Prostate. 29: 282-6. PMID 8899000 DOI: 10.1002/(Sici)1097-0045(199611)29:5<282::Aid-Pros2>3.0.Co;2-C |
0.4 |
|
| 1996 |
McGarvey T, Hussain MM, Stearns ME. In situ hybridization studies of alpha 2-macroglobulin receptor and receptor-associated protein in human prostate carcinoma. The Prostate. 28: 311-7. PMID 8610058 DOI: 10.1002/(Sici)1097-0045(199605)28:5<311::Aid-Pros7>3.0.Co;2-E |
0.391 |
|
| 1995 |
McGarvey TW, Stearns ME. Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Experimental and Molecular Pathology. 63: 52-62. PMID 8759054 DOI: 10.1006/exmp.1995.1030 |
0.447 |
|
| 1993 |
Stearns ME, Stearns M. Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion. Cancer Metastasis Reviews. 12: 39-52. PMID 8448826 DOI: 10.1007/Bf00689789 |
0.498 |
|
| 1991 |
Wang M, Stearns ME. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. Differentiation; Research in Biological Diversity. 48: 115-25. PMID 1773917 DOI: 10.1111/J.1432-0436.1991.Tb00250.X |
0.483 |
|
| Show low-probability matches. |